DDR1 is highly expressed in pediatric high-grade gliomas [180] as well as adult gliomas, irrespective of grades [181], where cells overexpressing the receptor show enhanced invasion and migration, likely as a result of activation of MMP2 [182]. The gene discussed is MMP2; the disease is central nervous system cancer.